CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
LysoMod aims to advance personalized medicine for lysosomal dysfunction disorders by fostering collaboration among experts in various scientific fields. The project focuses on understanding lysosomal function to develop new therapies for conditions like lysosomal storage diseases and neurodegenerative disorders.
LysoMod will innovate in the area of personalized medicine for disorders linked to lysosomal dysfunction.
This will be achieved by implementing a collaborative staff-exchange program between highly complementary and multidisciplinary academic and non-academic partners with expertise in pharmacology, medicinal chemistry, cell biology, biochemistry, mouse and human genetics, transcriptomics, proteomics and lipidomics.
Based on the critical role that lysosomes play in cells, a better understanding…
INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
United Kingdom, Oxford
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
United Kingdom, Brighton
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Israel, Rehovot
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Italy, Roma
Type: Research institute
Activity type: Research Organisations
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
